Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/π interaction

Bioorganic & Medicinal Chemistry
2008.0

Abstract

Phorbol ester-type tumor promoters such as indolactam-V (IL-V, 1) bind to the C1 domains of protein kinase C (PKC) isozymes. A more convenient method to investigate the interaction between each tumor promoter and PKC C1 domain is needed. Focusing on our recent finding that the indole ring of IL-V is involved in the CH/pi interaction with Pro-11 of the PKCdelta-C1B domain, we developed new fluorescent probes (2-4) from IL-V by forming a pyrroloindazole ring. Compound 2 without a substituent at the pyrroloindazole ring bound most strongly to PKC C1 domains with a potency similar to IL-V, but its fluorescent intensity was the weakest of any of the probes. Although the binding affinity of 3 with a methyl group was significantly weaker than that of IL-V, 4 with a trifluoromethyl group showed moderate affinity and the most potent fluorescence intensity. The fluorescence intensity and emission maxima of 4 changed significantly when bound to the PKCdelta-C1B peptide in both the presence and absence of phosphatidylserine. These results suggest that 4 could be a useful probe for analyzing the interaction of tumor promoters with PKC C1 domains.

Knowledge Graph

Similar Paper

Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/π interaction
Bioorganic & Medicinal Chemistry 2008.0
Synthesis, Conformational Analysis, and Biological Evaluation of 1-Hexylindolactam-V10 as a Selective Activator for Novel Protein Kinase C Isozymes
Journal of Medicinal Chemistry 2008.0
The amide hydrogen of (−)-indolactam-V and benzolactam-V8’s plays a critical role in protein kinase c binding and tumor-promoting activities
Bioorganic & Medicinal Chemistry Letters 2001.0
Modeling, Chemistry, and Biology of the Benzolactam Analogues of Indolactam V (ILV). 2. Identification of the Binding Site of the Benzolactams in the CRD2 Activator-Binding Domain of PKCδ and Discovery of an ILV Analogue of Improved Isozyme Selectivity
Journal of Medicinal Chemistry 1997.0
Synthesis of the benzofuran analogue of ILV, a new protein kinase C (PKC) activator
Bioorganic & Medicinal Chemistry Letters 1994.0
Probing the Binding of Indolactam-V to Protein Kinase C through Site-Directed Mutagenesis and Computational Docking Simulations
Journal of Medicinal Chemistry 1999.0
Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V
Bioorganic & Medicinal Chemistry Letters 2000.0
Novel indolocarbazole protein kinase c inhibitors with improved biochemical and physicochemical properties
Bioorganic & Medicinal Chemistry Letters 1995.0
Synthesis of structural analogs of lyngbyatoxin A and their evaluation as activators of protein kinase C
Journal of Medicinal Chemistry 1991.0
Design and Evaluation of Naphthol- and Carbazole-Containing Fluorescent σ Ligands as Potential Probes for Receptor Binding Studies
Journal of Medicinal Chemistry 2007.0